- The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase
-
Jeong WK, Kim YK, Song KD, Choi D, Lim HK
- KMID: 1730880
- Clin Mol Hepatol.
- 2013 Dec;19(4):360-366.
- doi: 10.3350/cmh.2013.19.4.360
Hepatocyte specific contrast agents including gadoxetic acid and gadobenate dimeglumine are very useful to diagnose various benign and malignant focal hepatic lesions and even helpful to estimate hepatic functional reservoir.... -
- CITED
-
- Close
- SHARE
-
- Close
- Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions
-
Jang JY, Kim MY, Jeong SW, Kim TY, Kim SU, Lee SH, Suk KT, Park SY, Woo HY, Kim SG, Heo J, Baik SK, Kim HS, Tak WY
- KMID: 1493569
- Clin Mol Hepatol.
- 2013 Mar;19(1):1-16.
- doi: 10.3350/cmh.2013.19.1.1
The application of ultrasound contrast agents (UCAs) is considered essential when evaluating focal liver lesions (FLLs) using ultrasonography (US). Microbubble UCAs are easy to use and robust; their use poses... -
- CITED
-
- Close
- SHARE
-
- Close
- Visualization of Tumor Angiogenesis Using MR Imaging Contrast Agent Gd-DTPA-anti-VEGF Receptor 2 Antibody Conjugate in a Mouse Tumor Model
-
Jun HY, Yin HH, Kim SH, Park SH, Kim HS, Yoon KH
- KMID: 984899
- Korean J Radiol.
- 2010 Aug;11(4):449-456.
- doi: 10.3348/kjr.2010.11.4.449
OBJECTIVE: To visualize tumor angiogenesis using the MRI contrast agent, Gd-DTPA-anti-VEGF receptor 2 antibody conjugate, with a 4.7-Tesla MRI instrument in a mouse model. MATERIALS AND METHODS: We designed a... -
- CITED
-
- Close
- SHARE
-
- Close
- Diffusion-Weighted MR Imaging before and after Contrast Enhancement with Superparamagnetic Iron Oxide for Assessment of Hepatic Metastasis
-
Kim H, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW
- KMID: 1716885
- Yonsei Med J.
- 2012 Jul;53(4):825-833.
- doi: 10.3349/ymj.2012.53.4.825
PURPOSE: The purpose of our study was to validate diffusion-weighted MRI (DWI) before and after superparamagnetic iron oxide (SPIO) injection for assessment of hepatic metastases. MATERIALS AND METHODS: Eighty-six hepatic metastases... -
- CITED
-
- Close
- SHARE
-
- Close
